Comparative analysis of toxicity of treatment protocols ALL-BFM-95m and ALL-MB-2008 for acute lymphoblastic leukemia in children in Uzbekistan

dc.contributor.authorBakhramov S.M.
dc.contributor.authorIbragimova S.Z
dc.date.accessioned2026-01-01T20:40:12Z
dc.date.issued2022-06-13
dc.description.abstractOver the past two decades, significant progress in the treatment of children with acute lymphoblastic leukemia has been made in many countries, also in low- and middleincome countries (LMICs), but survival rates remain significantly lower than in developed countries [2,5,6]. Inadequate Accompanying therapy and the resulting high mortality from toxicity are important reasons for treatment failure in children with acute lymphoblastic leukemia in LMICs
dc.formatapplication/pdf
dc.identifier.urihttps://geniusjournals.org/index.php/esh/article/view/1701
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/65859
dc.language.isoeng
dc.publisherGenius Publishing Group
dc.relationhttps://geniusjournals.org/index.php/esh/article/view/1701/1516
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceEurasian Scientific Herald; Vol. 9 (2022): ESH; 56-59
dc.source2795-7365
dc.subjectlymphoblastic
dc.subjectleukemia
dc.subjectresulting
dc.subjecttoxicity
dc.titleComparative analysis of toxicity of treatment protocols ALL-BFM-95m and ALL-MB-2008 for acute lymphoblastic leukemia in children in Uzbekistan
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
sm_2022_comparative_analysis_of_toxicity_of_trea.pdf
item.page.filesection.size
252.74 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections